Our findings support a “licensing” role of Blnc1 and its protein partners in obesity-linked activation of hepatic lipogenesis and NAFLD pathogenesis (Fig. 10d). This evidence concerns the gene PAQR9 and obesity due to melanocortin 4 receptor deficiency.